Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer.

被引：0
|
作者：
Hassan, R
Remaley, AT
Sampson, M
Zhang, JL
Cox, DD
Pingpank, J
Alexander, R
Willingham, M
Pastan, I
Onda, M
机构：
[1] Natl Canc Inst, Bethesda, MD USA
[2] Natl Inst Hlth, Bethesda, MD USA
[3] Wake Forest Univ, Winston Salem, NC 27109 USA
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9137S / 9137S
页数：1
相关论文
共 50 条
  • [1] Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer
    Hassan, R
    Remaley, AT
    Sampson, ML
    Zhang, JL
    Cox, DD
    Pingpank, J
    Alexander, R
    Willingham, M
    Pastan, I
    Onda, M
    CLINICAL CANCER RESEARCH, 2006, 12 (02) : 447 - 453
  • [2] Serum proteins marker for early detection of ovarian cancer.
    Mor, G
    Visintin, I
    Zhao, H
    Schwartz, P
    Rutherford, T
    Yui, L
    Bray-Ward, P
    Ward, DC
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 839S - 839S
  • [3] Mesothelin: A new marker for the detection of mesothelioma
    不详
    ANTICANCER RESEARCH, 2005, 25 (6D) : 4804 - 4804
  • [4] Megakaryocyte potentiation factor cleaved from mesothelin precursor is a useful tumor marker in the serum of patients with mesothelioma
    Onda, Masanori
    Nagata, Satoshi
    Ho, Mitchell
    Bera, Tapan K.
    Hassan, Raffit
    Alexander, Richard H.
    Pastan, Ira
    CLINICAL CANCER RESEARCH, 2006, 12 (14) : 4225 - 4231
  • [5] Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients
    Ho, M
    Hassan, R
    Zhang, JL
    Wang, QC
    Onda, M
    Bera, T
    Pastan, I
    CLINICAL CANCER RESEARCH, 2005, 11 (10) : 3814 - 3820
  • [6] Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer
    Cristaudo, Alfonso
    Foddis, Rudy
    Vivaldi, Agnese
    Guglielmi, Giovanni
    Dipalma, Nicola
    Filiberti, Rosangela
    Neri, Monica
    Ceppi, Marcello
    Uzzi, Michela Pagan
    Ivaldi, Gian Paolo
    Mencoboni, Manlio
    Canessa, PierAlclo
    Ambrosino, Nicolino
    Chella, Antonio
    Mutti, Luciano
    Puntoni, Riccardo
    CLINICAL CANCER RESEARCH, 2007, 13 (17) : 5076 - 5081
  • [7] Serum Mesothelin for Early Detection of Asbestos-Induced Cancer Malignant Mesothelioma
    Creaney, Jenette
    Olsen, Nola J.
    Brims, Fraser
    Dick, Ian M.
    Musk, Arthur W.
    de Klerk, Nicholas H.
    Skates, Steven J.
    Robinson, Bruce W. S.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (09) : 2238 - 2246
  • [8] ERC/Mesothelin as a Marker for Chemotherapeutic Response in Patients with Mesothelioma
    Tajima, Ken
    Hirama, Michihiro
    Shiomi, Kazu
    Ishiwata, Toshiji
    Yoshioka, Masataka
    Iwase, Akihiko
    Iwakami, Shinichiro
    Yamazaki, Mariko
    Toba, Michie
    Tobino, Kazunori
    Sugano, Koji
    Ichikawa, Masako
    Hagiwara, Yoshiaki
    Takahashi, Kazuhisa
    Hino, Okio
    ANTICANCER RESEARCH, 2008, 28 (6B) : 3933 - 3936
  • [9] The serum hyaluronan is a potential marker for epithelial ovarian cancer.
    Anttila, M
    Hiltunen, E
    Tammi, R
    Heinonen, S
    Yliskoski, M
    Juhola, M
    Kosma, VM
    Tammi, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 470S - 470S
  • [10] Serum mesothelin for early detection of the asbestos-induced cancer malignant mesothelioma
    Creaney, Jenette
    Robinson, Bruce W. S.
    Segal, Amanda
    Musk, Arthur W.
    de Klerk, Nick
    Pass, Harvey I.
    Skates, Steven J.
    CANCER BIOMARKERS, 2008, 4 (03) : 169 - 170
12345